Antimicrobial Resistance and Molecular Interaction with Drugs

Authors

  • Sridhar Alagar Ramanujam Marriotss Ridge High School
  • Dr. Rajagopal Appavu Gifted Gabber
  • Jothsna Kethar Gifted Gabber

DOI:

https://doi.org/10.47611/jsrhs.v12i4.5894

Keywords:

Antimicrobial Resistance, Molecular Level, Solutions

Abstract

Recently, people have been tackling a new problem in healthcare: antimicrobial resistance. Due to drug use (more specifically, drug misuse) in the previous years, bacteria have developed a resistance to modern drugs. Antimicrobial resistance makes current drugs less helpful in fighting certain types of bacteria. This study navigates on the description of antimicrobial resistance, its effects, and its solutions. Understanding Antimicrobial Resistance reveals mechanisms that microorganisms employ to render antimicrobial agents impotent. Understanding this knowledge can help make drugs more effective not only in the present but also in the future. Factors influencing antimicrobial resistance, including antibiotic misuse and horizontal gene transfer, reveal insights into the evolutionary arms race between microbes and drugs. Exploring molecular interactions between organisms and drugs can reveal the complex relationship between antimicrobial agents and pathogens. Consequences of antimicrobial resistance and strategies to combat antimicrobial resistance is another aspect that assesses the impact on patient outcomes, healthcare expenditure, and societal well-being. Approaches in drug development are from the topics of genomics, proteomics, and structural biology to increase the effectiveness of drugs. In conclusion, understanding the relationship between drugs and microorganisms lays the foundation for innovative drug development and strategies to preserve antimicrobial efficacy. Understanding this knowledge will not only help us now but will safeguard the role of drugs in the future. 

Downloads

Download data is not yet available.

Author Biography

Jothsna Kethar, Gifted Gabber

CEO of Gifted Gabber

References or Bibliography

References

Rosini, R., Nicchi, S., Pizza, M., & Rappuoli, R. (2020). Vaccines against antimicrobial resistance. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01048

Brinkac, L., Voorhies, A. A., Gomez, A., & Nelson, K. E. (2017). The threat of antimicrobial resistance on the human microbiome. Microbial Ecology, 74(4), 1001–1008. https://doi.org/10.1007/s00248-017-0985-z

Dadgostar, P. (2019).

Antimicrobial Resistance: Implications and Costs

Infection and Drug Resistance, Volume 12, 3903–3910. https://doi.org/10.2147/idr.s234610

Bush, K., & Bradford, P. A. (2016). Β-Lactams and Β-Lactamase inhibitors: an overview. Cold Spring Harbor Perspectives in Medicine, 6(8), a025247. https://doi.org/10.1101/cshperspect.a025247

McEwen, S. A., & Collignon, P. (2018). Antimicrobial Resistance: a One Health Perspective. Microbiology Spectrum, 6(2). https://doi.org/10.1128/microbiolspec.arba-0009-2017

Munita, J. M., & Arias, C. A. (2016). Mechanisms of antibiotic resistance. Microbiology Spectrum, 4(2). https://doi.org/10.1128/microbiolspec.vmbf-0016-2015

Mesa-Varona, O., Chaintarli, K., Muller-Pebody, B., Anjum, M. F., Eckmanns, T., Norström, M., Boone, I., & Tenhagen, B. (2020).

Monitoring Antimicrobial Resistance and Drug Usage in the Human and Livestock Sector and Foodborne Antimicrobial Resistance in Six European Countries

Infection and Drug Resistance, Volume 13, 957–993. https://doi.org/10.2147/idr.s237038

Baquero, F., Martínez, J. L., Lanza, V. F., Rodríguez-Beltrán, J., Galán, J. C., Millan, A. S., Cantón, R., & Coque, T. M. (2021). Evolutionary pathways and trajectories in antibiotic resistance. Clinical Microbiology Reviews, 34(4). https://doi.org/10.1128/cmr.00050-19

Kok, M., Maton, L., Van Der Peet, M., Hankemeier, T., & Van Hasselt, J. G. C. (2022). Unraveling antimicrobial resistance using metabolomics. Drug Discovery Today, 27(6), 1774–1783. https://doi.org/10.1016/j.drudis.2022.03.015

Talaat, M., Zayed, B., Tolba, S., Abdou, E., Gomaa, M., Itani, D., Hutin, Y., & Hajjeh, R. (2022). Increasing antimicrobial resistance in World Health Organization Eastern Mediterranean Region, 2017–2019. Emerging Infectious Diseases, 28(4). https://doi.org/10.3201/eid2804.211975

World Health Organization: WHO. (2021). Antimicrobial resistance. www.who.int. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance

What Exactly is Antibiotic Resistance? (2022, October 5). Centers for Disease Control and Prevention. https://www.cdc.gov/drugresistance/about.html

What Exactly is Antibiotic Resistance? (2022, October 5). Centers for Disease Control and Prevention. https://www.cdc.gov/drugresistance/about.html

Penicillin's discovery and antibiotic resistance: lessons for the future? (2017, March 29). PubMed. https://pubmed.ncbi.nlm.nih.gov/28356901/

Cunha, C. B. (2018). Antimicrobial stewardship programs. Medical Clinics of North America, 102(5), 797–803. https://doi.org/10.1016/j.mcna.2018.04.003

Published

11-30-2023

How to Cite

Alagar Ramanujam, S., Appavu, R. ., & Kethar, J. . (2023). Antimicrobial Resistance and Molecular Interaction with Drugs. Journal of Student Research, 12(4). https://doi.org/10.47611/jsrhs.v12i4.5894

Issue

Section

HS Research Projects